INVO Bioscience Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 445.2%.

Top 18 shareholders own 3.63% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
1.42%	The Vanguard Group, Inc.	54,058	US$46.5k	0%	no data
0.65%	Geode Capital Management, LLC	24,852	US$21.4k	-7.36%	no data
0.49%	Sabby Management, LLC	18,624	US$16.0k	0%	0.07%
0.21%	UBS Asset Management AG	8,102	US$7.0k	13.2%	no data
0.2%	Andrea Goren	7,804	US$6.7k	4.6%	no data
0.18%	Tower Research Capital LLC	6,922	US$6.0k	40%	no data
0.17%	Steven Shum	6,581	US$5.7k	11.2%	no data
0.1%	Michael Campbell	3,840	US$3.3k	12.7%	no data
0.051%	Matthew Szot	1,960	US$1.7k	0%	no data
0.044%	Trent Davis	1,682	US$1.4k	0%	no data
0.041%	Barbara Ryan	1,580	US$1.4k	0%	no data
0.03%	Rebecca Messina	1,150	US$988.9	0%	no data
0.015%	Securities America Advisors, Inc.	559	US$480.8	0%	no data
0.014%	City National Rochdale, LLC	538	US$462.8	0%	no data
0.003%	Aspire Private Capital, LLC	115	US$98.9	0%	no data
0.00097%	Morgan Stanley, Investment Banking and Brokerage Investments	37	US$31.8	0%	no data
0.00047%	Wells Fargo & Company, Private Banking and Investment Banking Arm	18	US$15.4	5.88%	no data
0.00008%	The Gleason Group, Inc.	3	US$2.6	0%	no data